Using smartphones to track walking can help understand fatigue in MS patients.
The study looked at how well smartphones could measure walking patterns in people with multiple sclerosis (MS) compared to healthy individuals. They found that the smartphone could accurately track steps and how quickly someone walked, which can show how tired they are. About 3% to 15% of MS patients showed signs of getting tired more quickly when walking. The researchers noticed that when patients felt more tired, their step count and walking speed decreased. This means that using a smartphone to measure walking can help doctors better understand how fatigue affects MS patients.
This finding is important for MS patients because it offers a simple way to monitor how fatigue impacts their daily life. Just like a fitness tracker helps you see how much you move, smartphones can help track walking and fatigue levels. Caregivers can also use this information to better support patients by recognizing when they may be overdoing it. Healthcare providers can use this data to tailor treatments and therapies based on real-time feedback from the patients. Overall, it empowers patients and caregivers by providing valuable insights into managing fatigue.
The study had a small number of participants, which means more research is needed to confirm these findings. Also, the study only looked at specific walking tasks, so it might not reflect all daily activities. It's important for MS patients to remember that while this tool can be helpful, it should be used alongside other methods for managing fatigue.
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More5/1/2026
Study finds CD29 marks blood B cells that can enter the brain and become antibody-producing cells in
Read More5/1/2026
Study finds early detection, lower spinal fluid virus, and PML‑IRIS relate to better 1‑year outcomes
Read More5/1/2026
Study found fewer hospital diagnoses of antibody-positive autoimmune encephalitis during COVID-19, b
Read More3/1/2026
Study shows C5 inhibitors given during or soon after NMOSD attacks helped most patients stabilize or
Read More3/1/2026
Early OCT eye scans can often distinguish MOGAD from NMOSD optic neuritis, helping guide faster trea
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.